1. 1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 71(3): 209-249. [DOI:10.3322/caac.21660]

2. Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet, 145(1): 129-135. [DOI:10.1002/ijgo.12749]

3. Gennigens C, Jerusalem G, Lapaille L, De Cuypere M, Streel S, Kridelka F, et al. (2022) Recurrent or primary metastatic cervical cancer: current and future treatments. ESMO Open, 7(5): 100579. [DOI:10.1016/j.esmoop.2022.100579]

4. Benito V, Chiva L, Silva P, Esparza M, Arencibia O, Federico M, et al. (2017) Should the presence of metastatic para-aortic lymph nodes in locally advanced cervical cancer lead to more aggressive treatment strategies? J Minim Invasive Gynecol, 24(4): 609-616. [DOI:10.1016/j.jmig.2017.01.016]

5. Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. (2019) Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw, 17(1): 64-84. [DOI:10.6004/jnccn.2019.0001]

6. Liu B, Gao S, Li S (2017) A comprehensive comparison of CT, MRI, positron emission tomography or positron emission tomography/CT, and diffusion-weighted imaging-MRI for detecting the lymph node metastases in patients with cervical cancer: a meta-analysis based on 67 studies. Gynecol Obstet Investig, 82(3): 209-222. [DOI:10.1159/000456006]

7. Fischerova D, Froyman W, Burgetova A, Haldorsen IS, Gatti E, Cibula D (2024) The role of imaging in cervical cancer staging: ESGO/ESTRO/ESP guidelines. Cancers (Basel), 16(4): 775. [DOI:10.3390/cancers16040775]

8. Selman TJ, Mann CH, Zamora J, Appleyard TL, Khan KS (2008) Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ, 178(7): 855-862. [DOI:10.1503/cmaj.071124]

9. Choi HJ, Ju W, Myung SK, Kim Y (2010) Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis. Cancer Sci, 101(6): 1471-1479. [DOI:10.1111/j.1349-7006.2010.01532.x]

10. Balleyguier C, Sala E, Da Cunha T, Bergman A, Brkljacic B, Danza F, et al. (2011) Staging of uterine cervical cancer with MRI: guidelines of the European Society of Urogenital Radiology. Eur Radiol, 21(5): 1102-1110. [DOI:10.1007/s00330-010-1998-x]

11. Pujade-Lauraine E, Tredan O, Leary A, Mirza MR, Enomoto T, Takyar J, et al. (2022) Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: a systematic and scoping review. Gynecol Oncol, 167(2): 360-372. [DOI:10.1016/j.ygyno.2022.08.013]

12. Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie-Meder C, et al. (2018) The ESGO/ESTRO/ESP guidelines for the management of patients with cervical cancer. Radiother Oncol, 127(3): 404-416. [DOI:10.1016/j.radonc.2018.03.003]

13. Salani R, Khanna N, Frimer M, Bristow RE, Chen LM (2017) An update on post-treatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: Society of Gynecologic Oncology (SGO) recommendations. Gynecol Oncol, 146(1): 3-10. [DOI:10.1016/j.ygyno.2017.03.022]

14. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW (2010) Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol, 28(12): 2108-2113. [DOI:10.1200/JCO.2009.25.4151]

15. Zhang W, Cao Y, Ni X, Tong Y (2022) Study on the physical factors related to the exposure dose to organs at risk from radiotherapy for cervical cancer patients. Int J Radiat Res, 20(3): 587-591.

16. Cohen PA, Jhingran A, Oaknin A, Denny L. (2019) Cervical cancer. Lancet, 393(10167): 169-182. [DOI:10.1016/S0140-6736(18)32470-X]

17. Ciulla S, Cicchetti G, Aiello AA, Gigli S, Ninkova R, Miceli V, et al. (2022) Post-treatment imaging in patients with locally advanced cervical carcinoma. Front Oncol, 12: 1003930. [DOI:10.3389/fonc.2022.1003930]

18. Zhang H, Kong W, Chen S, Zhao X, Luo D, Xie Y (2022) Surgical staging of locally advanced cervical cancer: current status and research progress. Front Oncol, 12: 940807. [DOI:10.3389/fonc.2022.940807]

19. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obste, 105(2): 103-104. [DOI:10.1016/j.ijgo.2009.02.012]

20. Brockbank E, Kitchener F, Bryant A, Pomel C, Reynolds K (2013) Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer. Cochrane Database Syst Rev, 2013(3): CD008217. [DOI:10.1002/14651858.CD008217.pub3]

21. Köhler C, Mustea A, Marnitz S, Schneider A, Chiantera V, Ulrich U, et al. (2015) Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial. Am J Obstet Gynecol, 213(4): 503.e1-7. [DOI:10.1016/j.ajog.2015.05.026]

22. Lai CH, Hsueh S, Hong JH, Lee CL, Chou HH, Chang TC, et al. (2003) Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer. Gynecol Oncol, 89(1): 160-167. [DOI:10.1016/S0090-8258(03)00064-7]

23. Frumovitz M, Querleu D, Gil-Moreno A, et al. (2014) Lymphadenectomy in locally advanced cervical cancer study (LiLACS): phase III clinical trial comparing surgical with radiologic staging in patients with stages IB2-IVA cervical cancer. J Minim Invasive Gynecol, 21(1): 3-8. [DOI:10.1016/j.jmig.2013.07.007]

24. Pomel C, Magaud L, Bourgin C, Beguinot M, Benoit C, Naik R, et al. (2017) Survival effect of laparoscopic para-aortic staging in locally advanced cervical cancer: a retrospective cohort analysis. BJOG, 124(7): 1089-1094. [DOI:10.1111/1471-0528.14492]

25. Marnitz S, Tsunoda AT, Martus P, et al. (2020) Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (UTERUS-11) intergroup study. Int J Gynecol Cancer, 30(12): 1855-1861. [DOI:10.1136/ijgc-2020-001973]

26. Christogiannis C, Nearchou S, Pandis N, et al. (2022) The self-fulfilling prophecy of post-hoc power calculations. Am J Orthod Dentofacial Orthop, 161(3): 315-317. [DOI:10.1016/j.ajodo.2021.10.008]

27. Yang J, Dowdy SC, Magrina JF, Magtibay PM, Yi J, Langstraat CL, et al. (2020) Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: a propensity score-matched analysis. Gynecol Oncol, 156(2): 320-327. [DOI:10.1016/j.ygyno.2019.12.009]

28. Nasioudis D, Ramirez PT, Taunk NK (2022) Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation. Int J Gynecol Cancer, 32(6): 823-827. [DOI:10.1136/ijgc-2022-003394]

29. Jiang W, Zhong ML, Wang SL, Chen Y, Wang YN, Zeng SY, Liang MR (2024) Para-aortic and pelvic lymphadenectomy in locally advanced cervical cancer with pelvic lymph node metastasis. World J Surg Oncol, 22(1): 262. [DOI:10.1186/s12957-024-03540-0]

30. Gold MA, Tian C, Whitney CW, Rose PG, Lanciano R (2008) Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study. Cancer, 112(9): 1954-1962. [DOI:10.1002/cncr.23400]

31. Dabi Y, Schaeffer V, Carcopino X, Bendifallah S, Ouldamer L, Lavoue V, et al. (2018) The therapeutic value of surgical para-aortic staging in locally advanced cervical cancer: a multicenter cohort analysis from the FRANCOGYN study group. J Transl Med, 16(1): 326. [DOI:10.1186/s12967-018-1703-4]

32. Xu H, Zhang Q, Luo C, Wang M, Tian M, Sun X, Qin Q (2025) Survival benefit of surgical staging before radiotherapy in locally advanced cervical cancer: a pooled analysis. Cancer Sci. Epub ahead of print, [DOI:10.1111/cas.70136]

33. Molnar O, Suteu O, Mihutiu S, Lazar L (2024) Impact of PET/CT imaging with FDG in locally advanced cervical carcinoma-a literature review. Curr Oncol, 31(5): 2508-2526. [DOI:10.3390/curroncol31050188]

34. Gouy S, Morice P, Narducci F, Uzan C, Gilmore J, Kolesnikov-Gauthier H, et al. (2012) Nodal-staging surgery for locally advanced cervical cancer in the era of PET. Lancet Oncol,13(5): e212-e220. [DOI:10.1016/S1470-2045(12)70011-6]

35. Díaz-Feijoo B, Tejerizo Á, Benito V, Hernández A, Ruiz R, Domingo S, et al. (2020) Prognostic value and therapeutic implication of laparoscopic extraperitoneal paraaortic staging in locally advanced cervical cancer: a Spanish multicenter study. Ann Surg Oncol, 27(8): 2829-2839. [DOI:10.1245/s10434-020-08329-5]

36. Puga O, Rojas N, Saez N, Urzúa M, Saavedra M, Pérez MV, et al. (2022) The role of pre-treatment paraaortic surgical staging for cervical cancer in the EMBRACE criteria. Ecancermedicalscience, 16:1463. [DOI:10.3332/ecancer.2022.1463]

37. Ramirez PT, Jhingran A, Macapinlac HA, Euscher ED, Munsell MF, Coleman RL, et al. (2011) Laparoscopic extraperitoneal para-aortic lymphadenectomy in locally advanced cervical cancer: a prospective correlation of surgical findings with positron emission tomography/computed tomography findings. Cancer, 117(9): 1928-1934. [DOI:10.1002/cncr.25739]

38. Gouy S, Samouelian V, Chargari C, Terroir M, Grimaldi S, Ilenko A, et al. (2021) False negative rate at 18F-FDG PET/CT in para-aortic lymph node involvement in patients with locally advanced cervical cancer: impact of PET technology. BMC Cancer, 21(1): 135. [DOI:10.1186/s12885-021-07821-9]

39. Liu H, Chen Y, Chang C, Zhou Z, Zhang Y, Ma C, et al. (2024) Development and validation of an 18F-FDG PET/CT radiomics nomogram for predicting progression-free survival in locally advanced cervical cancer: a retrospective multicenter study. BMC Cancer, 24(1): 150. [DOI:10.1186/s12885-024-11917-3]

40. Yun BS, Lee KB, Lee KH, Chang HK, Kim JY, Lim MC, et al. (2024) Korean gynecologic oncology group (KGOG) ınvestigators. Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial). J Gynecol Oncol, 35(5): e57. [DOI:10.1016/j.ijgc.2024.101595]